SARAH DISANTO: Open Payments
NPI 1043695778 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 10 payments from 8 companies in 2025. Trend: 2023 $86 · 2024 $867 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Straumann USA LLC | 1 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $19 |
Products named: ENTYVIO, RINVOQ, VOQUEZNA, VELSIPITY, Wegovy, MYRISK, TREMFYA.
Industry payments across NY — which companies pay providers there.
